Literature DB >> 2445073

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

A Zeevi1, R Duquesnoy, G Eiras, H Rabinowich, S Todo, L Makowka, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445073      PMCID: PMC2978964     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.

Authors:  T Ochiai; K Nakajima; M Nagata; T Suzuki; T Asano; T Uematsu; T Goto; S Hori; T Kenmochi; T Nakagoori
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

2.  Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients.

Authors:  A Zeevi; J Fung; T R Zerbe; C Kaufman; B S Rabin; B P Griffith; R L Hardesty; R J Duquesnoy
Journal:  Transplantation       Date:  1986-05       Impact factor: 4.939

3.  Functional characterization of infiltrating T lymphocytes in human hepatic allografts.

Authors:  J J Fung; A Zeevi; T E Starzl; J Demetris; S Iwatsuki; R J Duquesnoy
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

4.  IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION.

Authors:  S Todo; L Makowka; T Starzl
Journal:  Surg Res Commun       Date:  1987-01-01
  4 in total
  41 in total

Review 1.  FK 506 and autoimmune disease: perspective and prospects.

Authors:  A W Thomson; T E Starzl
Journal:  Autoimmunity       Date:  1992       Impact factor: 2.815

Review 2.  The present state of liver transplantation and the future prospects for intestinal transplantation.

Authors:  T E Starzl
Journal:  Immunol Invest       Date:  1989 Jan-May       Impact factor: 3.657

3.  Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.

Authors:  J J Fung; S Todo; A Jain; J McCauley; M Alessiani; C Scotti; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

4.  Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.

Authors:  A Zeevi; G Eiras; F H Bach; J J Fung; S Todo; T Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

5.  Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.

Authors:  A Zeevi; G Eiras; G Burckart; A Jain; A Kragack; R Venkataramanan; S Todo; J Fung; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

6.  The effect of FK 506 and CyA on the Lewis rat renal ischemia model.

Authors:  M A Nalesnik; H S Lai; N Murase; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

7.  Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506.

Authors:  G Eiras; O Imventarza; N Murase; Y Ueda; S Todo; T Starzl; R J Duquesnoy; A Zeevi
Journal:  Transplantation       Date:  1990-06       Impact factor: 4.939

8.  FK 506 has no short-term effects on endogenous or exogenous myeloid reconstitution in irradiated mice.

Authors:  S Boggs; K Patrene; F Vecchini; P Markus; M Cooper; R Duquesnoy; T E Starzl; W Bloomer
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

9.  Retrospective analysis of the correlation between tacrolimus concentrations measured in whole blood and variations of blood cell counts in patients undergoing allogeneic haematopoietic stem cell transplantation.

Authors:  Naoki Yoshikawa; Shuhei Urata; Kazuya Yasuda; Hiroshi Sekiya; Yasutoshi Hirabara; Manabu Okumura; Ryuji Ikeda
Journal:  Eur J Hosp Pharm       Date:  2018-11-16

10.  Dose study of the immunosuppression of FK 506 in canine lung allo-transplantation.

Authors:  T Fujisawa; Y Saitoh; N Urabe; T Takeda; Y Sekine; M Baba; Y Yamaguchi
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.